Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Communications Année : 2023

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

Dates et versions

hal-04390884 , version 1 (12-01-2024)

Identifiants

Citer

François Bertucci, Alexandre de Nonneville, Pascal Finetti, Emilie Mamessier. Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer. Cancer Communications, 2023, 43 (8), pp.943-946. ⟨10.1002/cac2.12447⟩. ⟨hal-04390884⟩

Collections

CNRS UNIV-AMU CRCM
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More